title: Efficacy of a surfactant, allantoin, and benzalkonium chloride solution for onychomycosis. Preliminary results of treatment with periodic debridement.
abstract: A 10-month, hospital-based, open-label clinical study was undertaken of a unique antimicrobial nail solution containing surfactant, allantoin, and benzaikonium chloride to determine its effectiveness, in conjunction with periodic debridement, against pedal onychomycosis. Forty patients with microbial infection of the nails were enrolled in this study, in which a new, objective nail-scoring system was used. At the start of the study, the mean nail score was 8.3, and 79.8% of the nails scored had severe disease (on a scale of 0 to 10, with 10 defined as total nail involvement, accompanied by pain and thickening). By the conclusion of the study, the mean score had decreased to 2.5, 32.6% of the patients' nails were scored 0 or 1, and 90% of the patients subjectively judged their improvement as excellent or good.
authors: Family Practice Clinic, Pacific Hospital of Long Beach, CA., USA.
authors: P S
authors: PS
authors: Wadhams
authors: J
authors: J
authors: Griffith
authors: P
authors: P
authors: Nikravesh
authors: D
authors: D
authors: Chodosh
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000481:Allantoin / Q000627:therapeutic use*; D000891:Anti-Infective Agents, Local / Q000627:therapeutic use*; D001548:Benzalkonium Compounds / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D003646:Debridement; D004643:Emollients / Q000627:therapeutic use; D005260:Female; D005533:Foot Dermatoses / Q000628:therapy; D006801:Humans; D008297:Male; D008875:Middle Aged; D014009:Onychomycosis / Q000628:therapy*; D012996:Solutions; D013501:Surface-Active Agents / Q000627:therapeutic use*
chemical_list: D000891:Anti-Infective Agents, Local; D001548:Benzalkonium Compounds; D004643:Emollients; D012996:Solutions; D013501:Surface-Active Agents; D000481:Allantoin